Healthcare -
Biotechnology - NASDAQ - US
$ 2.06
1.48 %
$ 432 M
Market Cap
-1.33
P/E
ALLO - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative ALLO - Allogene Therapeutics, Inc.
71.7 M
LAST VALUE
-1.65%
2 YEAR CAGR
11.83%
5 YEAR CAGR
0.00%
10 YEAR CAGR